Why the study?
What are the clinical and laboratory predictors of thrombosis and hemorrhage in pediatric ECMO nonsurvivors?
What are the clinical and laboratory predictors of thrombosis and hemorrhage in pediatric ECMO nonsurvivors?
Standard coagulation laboratory tests and heparin dosing are poor predictors of the highly frequent thrombosis and hemorrhage complications seen in pediatric ECMO nonsurvivors.
No takes yet. Share an insight, caveat, or question.
Urges caution relying on standard labs for pediatric ECMO anticoagulation; leaves open validation of superior predictors in prospective studies.
Reed et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: